What happened, in summary

Wyatt was in his 30s and already had a complex medical history when lung cancer entered his life unexpectedly. He had no obvious lung cancer symptoms and was shocked when cancer was found after dealing with issues related to a long-standing shunt. His doctor explained several treatment options, including chemotherapy, immunotherapy, radiation, and surgery, but surgery was crossed off. Treatment began with chemotherapy and immunotherapy together. Immunotherapy alone did not work, so his team returned to chemotherapy and later used different chemotherapy and immunotherapy combinations. He later learned that biomarker testing had helped guide some of those choices, though the exact variant was not clearly stated. About 2 years before this story, Wyatt received an intense regimen he called “Super Chemo”: 3 chemotherapy drugs plus 1 immunotherapy for 4 rounds. It shrank the cancer well but caused major side effects, including hair loss and blood-count problems. Afterward, 2 drugs were dropped. His ongoing plan was 1 chemotherapy every 2 weeks, alternating with another chemotherapy and immunotherapy. Wyatt also dealt with neuropathy, fatigue, chemo brain, nausea, kidney effects from treatment, and limits on clinical-trial eligibility related to kidney levels and HIV-positive status. As of August 2025, he was living with lung cancer, still in treatment, and focused on community, advocacy, and helping others find resources.